PHOENIX MEDICAL LTD.

Company Registration Number:
08921091 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2024

Period of accounts

Start date: 01 April 2023

End date: 31 March 2024

PHOENIX MEDICAL LTD.

Contents of the Financial Statements

for the Period Ended 31 March 2024

Balance sheet
Notes

PHOENIX MEDICAL LTD.

Balance sheet

As at 31 March 2024


Notes

2024

2023


£

£
Fixed assets
Tangible assets: 3 43,802 57,012
Total fixed assets: 43,802 57,012
Current assets
Stocks: 2,400,732 2,428,818
Debtors:   176,368 157,353
Cash at bank and in hand: 708,993 184,870
Total current assets: 3,286,093 2,771,041
Creditors: amounts falling due within one year:   (1,246,447) (1,594,277)
Net current assets (liabilities): 2,039,646 1,176,764
Total assets less current liabilities: 2,083,448 1,233,776
Creditors: amounts falling due after more than one year:   (1,883,511) (1,083,273)
Total net assets (liabilities): 199,937 150,503
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 199,837 150,403
Shareholders funds: 199,937 150,503

The notes form part of these financial statements

PHOENIX MEDICAL LTD.

Balance sheet statements

For the year ending 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 23 October 2024
and signed on behalf of the board by:

Name: George He
Status: Director

The notes form part of these financial statements

PHOENIX MEDICAL LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

PHOENIX MEDICAL LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2024

2. Employees

2024 2023
Average number of employees during the period 17 17

PHOENIX MEDICAL LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2024

3. Tangible Assets

Total
Cost £
At 01 April 2023 124,540
Additions 2,187
At 31 March 2024 126,727
Depreciation
At 01 April 2023 67,528
Charge for year 15,488
Other adjustments (91)
At 31 March 2024 82,925
Net book value
At 31 March 2024 43,802
At 31 March 2023 57,012